Abstract
Objectives
To investigate the association between sex and parathyroid hormone response to severe vitamin D deficiency after hip fracture.
Design
Cross-sectional study.
Setting
Rehabilitation hospital in Italy.
Participants
571 consecutive inpatients with hip fracture and severe vitamin D deficiency (serum 25-hydroxyvitamin D < 12ng/ml), without hypercalcemia or estimated glomerular filtration rate (GFR) < 15ml/min.
Measurements
In each patient we assessed PTH (by two-site chemiluminescent enzyme-labelled immunometric assay), 25-hydroxyvitamin D (by immunoenzymatic assay), albumin-adjusted total calcium, phosphate, magnesium, and creatinine 21.3 ± 6.1 (mean ± SD) days after fracture occurrence. Functional level was assessed using the Barthel index. PTH response to vitamin D deficiency was classified as either secondary hyperparathyroidism (serum PTH >75pg/ml) or functional hypoparathyroidism, i.e., inappropriate normal levels of PTH (≤75pg/ml).
Results
Among the 571 patients, 336 (59%) had functional hypoparathyroidism, whereas 235 (41%) had secondary hyperparathyroidism. PTH status was significantly different between sexes (p=0.003): we found functional hypoparathyroidism in 61% of women and 43% of men (secondary hyperparathyroidism in 39% of women and 57% of men). The significance of the between-sex difference was maintained after adjustment for age, estimated GFR, phosphate, albumin-adjusted total calcium, albumin, Barthel index scores, 25-hydroxyvitamin D, and hip fracture type (either cervical or trochanteric). The adjusted odds ratio was 1.85 (95%CI from 1.09 to 3.13; p=0.023).
Conclusions
Data shows that PTH response to vitamin D deficiency was sex-associated following a fracture of the hip. The higher prevalence of secondary hyperparathyroidism may play a role in the known prognostic disadvantage found in hip-fracture men.
Similar content being viewed by others
References
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 2001;22:477–501.
Bruce DG, St John A, Nicklason F, Goldswain PR. Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J Am Geriatr Soc 1999;47:354–359.
LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;2S1:1505–1511.
Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006;29:809–813.
Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, Smith PN. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci 2007;37:222–232.
Fisher A, Goh S, Srikusalanukul W, Davis M. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcif Tissue Int 2009;85:301–309.
Rolland Y, Abellan van Kan G, Bénétos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Trémollières F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging 2008;12:335–346.
Pioli G, Davoli ML, Pellicciotti F, Pignedoli P, Ferrari A. Comprehensive care. Eur J Phys Rehabil Med 2011;47:265–279.
Di Monaco M. Rehabilitation after hip fracture in older people. Eur J Phys Rehabil Med 2011;47:253–255.
Sahota O, Gaynor K, Harwood RH, Hosking DJ. Hypovitaminosis D and ‘functional hypoparathyroidism’ -the NoNoF (Nottingham Neck of Femur) study. Age Ageing 2001;30:467–472.
Bjorkman MP, Sorva AJ, Risteli J, Tilvis RS. Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency. J Am Geriatr Soc 2009;57:1045–1050.
Amouzougan A, Chopin F, Laporte S, Vico L, Thomas T. Functional hypoparathyroidism in postmenopausal women with fragility fracture. Joint Bone Spine 2011 (Epub ahead of print)
Fisher A, Srikusalanukul W, Davis M, Smith P. Hip fracture type: important role of parathyroid hormone (PTH) response to hypovitaminosis D. Bone 2010;47:400–407.
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 2009;20:1633–1650.
Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC, the National Osteoporosis Foundation, 2008.
Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R, European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399–428.
von Mühlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E. Vitamin D, parathyroid hormone levels and bone mineral den sit)’ in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int 2005;16:1721–1726.
Bischoff-Ferrari HA, Can U, Staehelin HB, Platz A, Henschkowski J, Michel BA, Dawson-Hughes B, Theiler R. Severe vitamin D deficiency in Swiss hip fracture patients. Bone 2008;42:597–602.
Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. 25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patient. J Bone Miner Metab 2006;24:42–47.
Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010;39:203–209.
Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD. Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 2011;22:2439–2448.
Morin S, Lix LM, Azimaee M, Metge C, Majumdar SR, Leslie WD. Institutionalization following incident non-traumatic fractures in community- dwelling men and women. Osteoporos Int 2012;DOI 10.1007/s00198-011-1815-7.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39S1:1–266.
Mahoney F, Barthel D. Functional evaluation: the Barthel index. Md State Med J 1965;14:61–65.
LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J (2008) Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 2008;19:1283–1290.
Glowacki J, LeBoff MS, Kolatkar NS, Thornhill TS, Harris MB. Importance of vitamin D in hospital-based fracture care pathways. J Nutr Health Aging. 2008;12:291–293.
Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Appendicular lean mass does not mediate the significant association between vitamin D status and functional outcome in hip-fracture women. Arch Pliys Med Rehabil 2011;92:271–276.
Wengstrom Y, Wahren LK, Grodzinsky E. Importance of dietary advice, nutritional supplements and compliance for maintaining body weight and body fat after hip fracture. J Nutr Health Aging 2009;13:632–638.
Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. Serum levels of insulin-like growth factor-I are positively associated with functional outcome after hip fracture in elderly women. Am J Phys Med Rehabil 2009;88:119–125.
Avenell A, Handoll HH. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2010;20:CD001880.
Reginster JY, Frederick I, Deroisy R, Dewe W, Taquet AN, Albert A, Collette J, Pirenne H, Zheng SX, Gosset C. Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly women. Osteoporos Int 1998;8:390–392.
Haden ST, Brown EM, Hurwitz S, Scott J, El-Hajj Fuleihan G The effects of age and gender on parathyroid hormone dynamics. Clin Endocrinol 2000;52:329–338.
Levin A, Bakris GL, Moliteh M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31–38.
Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E Mineral metabolism parameters throughout chronic kidney disease stages 1-5—achievement of K/DOQI target ranges. Nephrol Dial Transplant 2007;22:1171–1176.
Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:131–141.
Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Acute-onset hypomagnesemia-induced hypocalcemia caused by refractoriness of bones and renal tubules to parathyroid hormone. J Bone Miner Metab 2011;29:752–755.
Maguire ME. Hormone-sensitive Mg transport and Mg regulation of adenylate cyclase. Trends Pharmacol Sci 1994;5:73–77.
Zaloga GP. Interpretation of the serum Mg level. Chest 1989;95:257–258.
Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006; 17:1013–1021.
Sahota O, Mundey MK, San P, Godber M, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35:312–319.
Zajac JD. Regulation of parathyroid function. Bone 2000;27:7s.
Madsen CM, Jorgensen HL, Lind B, Ogarrio HW, Riis T, Schwarz P, Duus BR, Lauritzen JB. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice. Injury 2012. doi:10.1016/j.injury.2011.12.025.
Mastaglia SR, Seijo M, Muzio D, Somoza J, Nunez M, Oliven B. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty- five years. J Nutr Health Aging. 2011;15:349–354.
Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging. 2009;13:893–898.
Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxyvitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004;89:5477–5481.
Chen JS, Sambrook PN, March L, Cameron ID, Cumming RG, Simpson JM, Seibel MJ. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol 2008; 68:290–298.
Bjorkman MP, Sorval AI, Tilvis RS. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol 2008;158:749–753.
Peiris AN, Youssef D, Grant WB. Secondary hyperparathyroidism: Benign bystander or culpable contributor to adverse health outcomes? South Med J 2012; 105:36–42.
Barone A, Giusti A, Pioli G Hypovitaminosis D and secondary hyperparathyroidism in the elderly: risk factors for hip fracture or markers of frailty? Osteoporos Int 2007;18:1561–1562.
Salminen H, Saaf M, Ringertz H, Strender LE. The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women. Osteoporos Int 2008;19:201–209.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Monaco, M., Castiglioni, C., Vallero, F. et al. Parathyroid hormone response to severe vitamin D deficiency is sex associated: An observational study of 571 hip fracture inpatients. J Nutr Health Aging 17, 180–184 (2013). https://doi.org/10.1007/s12603-012-0088-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-012-0088-y